Trial intelligence / Profile preview

Intraoperative triamcinolone injection at wound edges in thyroidectomy: scar outcome RCT

TCTR20260711017Phase 2Not yet recruiting

Sponsor
Mahidol University
Start
Jul 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of triamcinolone in severe cutaneous adverse reactions (SCAR), sponsored by Mahidol University. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

triamcinolone
03

Conditions

severe cutaneous adverse reactions (SCAR)

Beyond the preview

Go deeper on TCTR20260711017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260711017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call